Reference
Sanofi. Sanofi Discontinues Clinical Development of Investigational JAK2 Agent Fedratinib (SAR302503). Media Release : 18 Nov 2013. Available from: URL: http://en.sanofi.com
Rights and permissions
About this article
Cite this article
Clinical development of fedratinib discontinued. Reactions Weekly 1480, 2 (2013). https://doi.org/10.1007/s40278-013-7385-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-7385-z